2018-12-01
Rebuttal Letter to the Editor Kloosterboer et al., Therapeutic Drug Monitoring 2018;40: 344-350
Publication
Publication
Therapeutic Drug Monitoring , Volume 40 - Issue 6 p. 762
Additional Metadata | |
---|---|
doi.org/10.1097/FTD.0000000000000560, hdl.handle.net/1765/112347 | |
Therapeutic Drug Monitoring | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Kloosterboer, S.M, de Winter, B.C.M, Bahmany, S, Al-Hassany, L. (Linda), Dekker, A. (Annet), Dieleman, G.C, … Koch, B.C.P. (2018). Rebuttal Letter to the Editor Kloosterboer et al., Therapeutic Drug Monitoring 2018;40: 344-350. Therapeutic Drug Monitoring, 40(6). doi:10.1097/FTD.0000000000000560
|